FY2022-2026 DTRA Chemical / Biological Technologies Broad Agency Announcement
Awarded on June 2, 2026. Full description on SAM.gov.
Overview
- Posted
- June 3, 2026
- Notice type
- Award Notice
- NAICS
- NAICS 5417 Scientific Research and Development Services (reported as 541700)
- Agency
- Department of WarDEFENSE THREAT REDUCTION AGENCY (DTRA)
Notice details
- Office
- DEFENSE THREAT REDUCTION AGENCY
- Place of performance
- Annapolis, Maryland, 21401
- Last updated
- Oct 29, 2026
- First published
- Last updated on SAM.gov
- Award date
- Jun 2, 2026
- Award amount (SAM.gov award notice)
- $9.5M
Identifiers
- Solicitation number
- HDTRA126C0003
- Notice ID
- 3471ca3e807346d69eaeb3e95d058a45
- Award number (PIID)
- HDTRA126C0003
Description
HDTRA126C0003 is a cost plus fee contract awarded via full and open competition under Broad Agency Announcement (BAA), HDTRA122S0002, Topic Call 5.
Award Overview
Award Number
HDTRA126C0003
Award Amount (SAM.gov award notice)
$9.5M
Award Date
Jun 2, 2026
Awardee
Awardee UEI
HC4YMJZ9X9P3
Awardee CAGE Code
7CAF6
Awardee Address
Annapolis, MD 21401, UNITED STATES
Original Solicitation
Notice ID: 3471ca3e807346d69eaeb3e95d058a45
Posted Date: Jun 3, 2026
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $508.9KSigned Aug 27, 2025
- $501.2KSigned Apr 30, 2025
- $501.2KSigned Nov 12, 2024
Contacts
Contracting Officer
Primary Contact
Documents
Files (27)
- Download
TOPIC CALL 7 Q and A_Ph I.pdf
173 KBAdded in Solicitation version 22Posted - Download
TOPIC CALL 7.pdf
119 KBAdded in Solicitation version 21Posted - Download
ATTACHMENT 7 - Pre-award Survey of Prospective Contractor Accounting System Checklist_REVISED August 2025.pdf
292 KBAdded in Solicitation version 20Posted - Download
ATTACHMENT 6 - Reps and Certs_REVISED August 2025.pdf
279 KBAdded in Solicitation version 20Posted - Download
HDTRA122S0002_BAA_REVISED August 2025.pdf
496 KBAdded in Solicitation version 20Posted - Download
TOPIC CALL 6 Q and A_Ph I.pdf
50 KBAdded in Solicitation version 19Posted - Download
TOPIC CALL 6.pdf
128 KBAdded in Solicitation version 18Posted - Download
TOPIC CALL 5 Q and A_Ph II.pdf
92 KBAdded in Solicitation version 17Posted - Download
TOPIC CALL 4 Q and A_Ph II.pdf
117 KBAdded in Solicitation version 17Posted - Download
TOPIC CALL 5 Q and A_Ph I.pdf
66 KBAdded in Solicitation version 16Posted - Download
TOPIC CALL 4 Q and A_Ph I.pdf
121 KBAdded in Solicitation version 15Posted - Download
TOPIC CALL 5.pdf
291 KBAdded in Solicitation version 14Posted - Download
ATTACHMENT 4 - Supplemental Volume Cover Sheet_Rev April 2024.pdf
250 KBAdded in Solicitation version 13Posted - Download
TOPIC CALL 4.pdf
239 KBAdded in Solicitation version 13Posted - Download
TOPIC CALL 3 Q and A.pdf
54 KBAdded in Solicitation version 12Posted - Download
TOPIC CALL 3 ROM Template.xlsx
25 KBAdded in Solicitation version 10Posted - Download
TOPIC CALL 3 SUBMISSION AND EVALUATION INFORMATION.pdf
152 KBAdded in Solicitation version 9Posted - Download
TOPIC CALL 3.pdf
163 KBAdded in Solicitation version 9Posted - Download
TOPIC CALL 2 Q and A_Ph II.pdf
55 KBAdded in Solicitation version 8Posted - Download
TOPIC CALL 2 Q and A _Ph I.pdf
54 KBAdded in Solicitation version 7Posted - Download
TOPIC CALL 2.pdf
180 KBAdded in Solicitation version 6Posted - Download
TOPIC CALL 1 Q and A_Ph II.pdf
48 KBAdded in Solicitation version 5Posted - Download
TOPIC CALL 1.pdf
282 KBAdded in Solicitation version 2Posted - Download
ATTACHMENT 1 TRL Definitions.pdf
175 KBAdded in Solicitation version 2Posted - Download
ATTACHMENT 2 - SOW Template.pdf
162 KBAdded in Solicitation version 2Posted - Download
ATTACHMENT 3 - Data Rights Assertions List.docx
13 KBAdded in Solicitation version 2Posted - Download
ATTACHMENT 5 - Cost Proposal Template.xlsx
85 KBAdded in Solicitation version 2Posted
Lifecycle
- 1Version 1Solicitation
FY2022-2026 DTRA Chemical / Biological Technologies Broad Agency Announcement
- 4Version 4Award NoticeArchivedCurrent
Type changed from Solicitation to Award Notice
FY2022-2026 DTRA Chemical / Biological Technologies Broad Agency Announcement
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
UPDATED AUGUST 25, 2026: TOPIC CALL 7, QUESTIONS & ANSWERS (Q and A_Ph I) UPDATED JULY 8, 2026: TOPIC CALL 7 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO THE TOPICS INCLUDED IN TOPIC CALL 7 IS JULY 22, 2026. THE DEADLINE TO SUBMIT A PROPOSAL FOR THE TOPICS INCLUDED IN TOPIC CALL 7 IS SEPTEMBER 2, 2026 AT 2:00PM EDT. UPDATED AUGUST 20, 2025: SECTIONS 4.8.2.3.1, 4.8.2.3.8, AND 9.0 OF THE BAA HAVE BEEN REVISED AND SECTION 4.8.2.3.17 HAS BEEN ADDED. ATTACHMENTS 6 AND 7 HAVE BEEN REVISED. UPDATED MARCH 11, 2025: TOPIC CALL 6, QUESTIONS & ANSWERS (Q and A_Ph I) UPDATED FEBRUARY 13, 2025: TOPIC CALL 6 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO THE TOPICS INCLUDED IN TOPIC CALL 6 IS FEBRUARY 27, 2025. THE DEADLINE TO SUBMIT A PROPOSAL FOR THE TOPICS INCLUDED IN TOPIC CALL 6 IS APRIL 10, 2025 AT 2:00PM EDT. UPDATED AUGUST 30, 2024: TOPIC CALL 5, QUESTIONS & ANSWERS (Q and A_Ph II) UPDATED AUGUST 30, 2024: TOPIC CALL 4, QUESTIONS & ANSWERS (Q and A_Ph II) UPDATED JUNE 6, 2024: TOPIC CALL 5, QUESTIONS & ANSWERS (Q and A_PhI) UPDATED MAY 10, 2024: TOPIC CALL 4, QUESTIONS & ANSWERS (Q and A_Ph I) UPDATED APRIL 30, 2024: TOPIC CALL 5 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO THE TOPIC INCLUDED IN TOPIC CALL 5 IS MAY 14, 2024. THE DEADLINE TO SUBMIT A PROPOSAL FOR THE TOPIC INCLUDED IN TOPIC CALL 5 IS JUNE 25, 2024 AT 2:00PM EDT. UPDATED APRIL 1, 2024: TOPIC CALL 4 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO TOPICS INCLUDED IN TOPIC CALL 4 IS APRIL 16, 2024. THE DEADLINE TO SUBMIT A PROPOSAL FOR TOPICS INCLUDED IN TOPIC CALL 4 IS MAY 29, 2024 AT 2:00PM EDT. UPDATED SEPTEMBER 29, 2023: TOPIC CALL 3, QUESTIONS & ANSWERS (Q and A) UPDATED SEPTEMBER 6, 2023: TOPIC CALL 3 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO TOPICS INCLUDED IN TOPIC CALL 3 IS SEPTEMBER 18, 2023. THE DEADLINE TO SUBMIT A PROPOSAL FOR TOPICS INCLUDED IN TOPIC CALL 3 IS OCTOBER 26, 2023 AT 2:00PM EDT. UPDATED AUGUST 14, 2023: TOPIC CALL 2, QUESTIONS & ANSWERS (Q and A_Ph II) UPDATED APRIL 24, 2023: TOPIC CALL 2, QUESTIONS & ANSWERS (Q and A_Ph I) UPDATED MARCH 21, 2023: TOPIC CALL 2 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO TOPICS INCLUDED IN TOPIC CALL 2 IS MARCH 28, 2023. THE DEADLINE TO SUBMIT A PHASE I PROPOSAL FOR TOPICS INCLUDED IN TOPIC CALL 2 IS MAY 10, 2023 AT 2:00PM EDT. UPDATED NOV 10, 2022: TOPIC CALL 1, QUESTIONS & ANSWERS (Q and A_Ph II) The purpose of this BAA is to serve as a five-year (60-month) open continuous vehicle through which topics will be released as individual calls as they become available during the BAA open period. This BAA will remain open for five years from the date of release. The scope of this BAA is limited to projects that meet Technology Readiness Level (TRL) definitions in the TRL range of 3-6 (see ATTACHMENT 1 for TRL definitions). Upon completion of the proposed development efforts, solutions should strive to meet a TRL in the range of 4-6. Proposals that address technologies at TRL 4 or greater should also be aware of the Manufacturing Readiness Level (MRL) considerations. The DTRA RD-CB mission was established by the Department of Defense (DoD) to provide state-of-the-art defense capabilities to allow military forces of the United States to operate and to successfully complete their missions in chemical and biological warfare environments. The scope of mission efforts and the priorities assigned to specific projects are influenced by changes in military and civilian Chemical and Biological Defense (CBD) science and technology, advanced developments, operational requirements, military threat assessments, and national defense strategies. To keep pace with defense capability requirements, the CBD Program (CBDP), as part of its mission, routinely promulgates chemical and biological research. The comprehensive research program encompasses both intramural and extramural sources, and the role of each is vital to the fulfillment of the CBDP objectives. DTRA is seeking optimum approaches to meet technology objectives with a goal to identify and select science and technology projects that can be transitioned to joint acquisition programs. | - | Solicitation | 08/16/2022 |
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0003 only extends the proposal due date). Amendment 0001 – removed alternate point of contact information under “Contract Information” on SAM.gov Amendment 0002 – revised proposal due date from: 12:00pm eastern, Friday, 23 Oct 2026 to: 12:00pm eastern Friday, 06 Nov 2026 Amendment 0003 – revised proposal due date from: 12:00pm eastern Friday, 06 Nov 2026 to: 12:00pm eastern Friday, 20 Nov 2026 | - | Solicitation | 11/20/2026 |
The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval. | - | Market Research | 11/16/2026 |
Amendment 0001 to this notice is to push out the anticipated posting of the solicitation to late November 2026. This is a pre-solicitation notice to synopsize the intention of the Defense Health Agency Contracting Activity (DHACA) to issue a Request for Proposal (RFP) for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle covering military medical research and development services. A historical pre-solicitation notice was posted under Notice ID# HT942626RE002, although there were various delays with getting a solicitation out in Fiscal Year 2026. This notice is taking over where Notice ID# HT942626RE002 left off. No further delays are anticipated at this time for this on-ramp. The eventual RFP will be set-aside for small businesses certified under the Small Business Administration 8(a) Program. The Government anticipates making multiple new awards under this on-ramp, and all new awards will align with the existing unrestricted contract vehicle. This notice is not a request for proposals and does not commit the Government to any contractual agreement. The OMNIBUS IV contract vehicle was awarded under full and open competition with a base ordering period of 20 June 2022 through 19 June 2027 and an Option Ordering Period of 20 June 2027 - 19 June 2032. Task orders may be competed under fair opportunity (providing all Contract Holders within a Market Segment the opportunity to submit a proposal) or an exception to fair opportunity (such as set-asides for small businesses or applicable small business socioeconomic categories). The cumulative ceiling of this unrestricted IDIQ contract vehicle is $10 billion. To date, the accumulated awarded task order value (including future unexercised option periods) is over $690 million across 61 task orders. Task Orders have been issued by a growing number of end users including DHACA, the U.S. Army Medical Research Acquisition Activity (now integrated into DHACA), the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. When excluding the task orders simply providing a minimum guarantee to the existing Contract Holders, 61 task orders have been issued off this contract vehicle with 8 task orders being set aside for the 8(a) Program and 15 task orders being awarded to an 8(a) Participant (based on the most recent representations at the contract level). 42 task orders have been awarded so far to small businesses under this contract vehicle. Of the 61 task orders, 95% were awarded during the Government Fiscal Years 2024 - 2026. Please see attachments for further details. | - | Pre-Solicitation | Open |
The Defense Health Agency Contracting Activity (DHACA) intends to issue a sole source award. The Defense Health Agency, Science and Technology Portfolio Management Division (STPMD) will co-sponsor a Forum on Traumatic Brain Injury (TBI) hosted by the National Academy of Science, Engineering, and Medicine (NASEM). The forum will provide STPMD on ongoing mechanism and neutral setting in which the full spectrum of Government stakeholders and public and private sector Subject Matter Experts (SMEs) to explore opportunities for collective action directed towards advancement in TBI care and research. The requirement contains a base year plus 4 option years. The NASEM will convene the Forum on TBI two (2) to three (3) times per year to provide and ongoing mechanism and neutral setting in which the full spectrum of Government stakeholders and public and private sector SMEs will share information and explore opportunities for collective action addressing contemporary topics in TBI and research. Forum members will address short- and long-term strategic planning for advancing TBI care and research spanning the full TBI continuum from prevention through acute care and rehabilitation. NASEM has established these forums as part of contract W81XWH22C0033. DHA is planning to participate as a key stakeholder. STPMD requires access to these Forums along with other military services and federal agencies. Any firm that believes it can provide the stated capability as outlined above are invited to submit a written notification to the Contracting Office NLT 2PM ET on 18 November 2026. Supporting evidence must be furnished in sufficient detail to demonstrate the firm’s ability to provide the stated capability. Information shall be sent electronically (via e-mail only) to Rich Trunnell, Contract Specialist, at richard.k.trunnell.civ@health.mil. No telephone requests will be accepted. Responses received will be evaluated; however; a determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, DHACA will proceed with the sole sources contract. | - | Special Notice | 11/18/2026 |
Additional Details
Solicitation Number
HDTRA126C0003
Archive Date
Jun 17, 2026
Office Address
FORT BELVOIR, VA, 22060-6201